IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Achillion Pharma CVR

CUSIP: 004CVR031 | 9 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Rhumbline Advisers35,209
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Rhumbline Advisers
35,209$00.0%IndexVery LowBoston, MA2026-11-10